#SKYCellflu
LightNews LightNews
newsen.bsky.social
SK bioscience Accelerates Global Outreach by Exporting Influenza Vaccines to Southern Hemisphere Markets#South_Korea#Seongnam#Influenza_vaccine#SK_bioscience#SKYCellflu
SK bioscience Accelerates Global Outreach by Exporting Influenza Vaccines to Southern Hemisphere Markets
SK bioscience has commenced the export of its SKYCellflu influenza vaccine to Southern Hemisphere markets, enhancing global vaccine access and production stability.
third-news.com
March 12, 2025 at 12:15 PM
l2plabs.bsky.social
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate
Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim results from the Phase 1/2 trial expected by 2027, aimed at entering the high-immunogenicity vaccine market "Our SKYCellflu platform with our adjuvanted vaccine...
dlvr.it
July 17, 2025 at 11:02 AM
news-feed.bsky.social
@TheKoreaHerald: South Korean pharmaceuticals firm SK Bioscience said Thursday that it exported its cell-cultured flu vaccine, SKYCellflu, to Thailand, marking its first entry into a market with southern hemisphere requirements.
https://t.co/MrEiVPmhIf
March 21, 2024 at 7:47 AM
news-feed.bsky.social
@YonhapNews: SK bioscience exports influenza vaccine SKYCellflu to Thailand https://t.co/PsWaWQITY9
March 21, 2024 at 5:04 AM
news-feed.bsky.social
@YonhapNews: SK bioscience to provide 5 mln doses of cell-based flu vaccine SKYCellflu https://t.co/cvovHc6gmx
August 23, 2023 at 7:01 AM